CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
CareDx announced that its precision medicine diagnostics will be featured in over 30 abstracts and 9 oral presentations at the 2026 American Transplant Congress, highlighting data from more than 110 transplant centers. Key findings in kidney transplantation suggest AlloSure is evolving into a clinical endpoint for risk assessment and treatment response, with a study of over 4,000 recipients linking persistent elevation to higher rates of rejection and graft loss.
Key figures
- Oral presentations
- 9
- Abstracts presented
- over 30
- Participating centers
- over 110
- Kidney study recipients
- more than 4,000
- Auroc rejection discrimination
- 0.79
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.